Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Knight Therapeutics Reports First Quarter 2024 Results
-
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
-
Kelly Reports First-Quarter 2024 Earnings
-
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Whole Earth Brands Reports First Quarter 2024 Results
-
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
-
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
-
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
-
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
-
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
-
Cronos Group Reports 2024 First Quarter Results
-
Destination XL Group, Inc. to Announce First Quarter 2024 Financial Results on May 30, 2024
-
SPS Commerce Acquires Traverse Systems
-
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
-
Zevra Therapeutics to Participate at Upcoming Investor Events
-
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
-
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2024
-
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Eos Energy Enterprises Announces Participation in Upcoming Investor Conferences
-
Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
-
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
-
Vital Farms Reports First Quarter 2024 Financial Results
-
Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 22, 2024
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
-
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - Tyman plc
-
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
-
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
-
Xometry Reports First Quarter 2024 Results
-
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
-
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
-
Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2024 Results
-
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Tower Semiconductor Reports 2024 First Quarter Financial Results
-
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
-
Treasury Metals and Blackwolf Announce Upsize to Concurrent Financing
-
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
-
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Optinose Announces $55 Million Registered Direct Offering
-
BioXcel Therapeutics Reports First Quarter 2024 Financial Results
-
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
-
Cerence Announces Second Quarter Fiscal Year 2024 Results

